12th - 13th March, 2020

4th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress

ILEC Conference Center and IBIS London Earls Court, 47 Lillie Road, London, SW6 1UD

In the past decade, many scientific breakthroughs have been achieved through research including success in recent years of cancer immunotherapy with monoclonal antibodies, cancer vaccines, adoptive cell therapy and immune-checkpoint therapy. Personalized immunotherapy with various combinations will be the next promising strategy for the future cancer treatment direction.

users

30+ experts from academia and industry will be presenting their current work in Immuno-Oncology, Latest updates on regulatory guidelines and approvals, Validation markers for tumor-derived T-cell subpopulations, NextGen T-Cell and CAR-T Cell therapy, Personalized Medicine, Biomarkers and Cancer Immunotherapy

users

Opportunity to develop long-lasting business relationships and networking opportunities with researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies, Universities, and Research institutes.

users

Over 20 presentations, round-tables, and panel discussions focused on the key opportunities and challenges in biomarker research, Validation methods and innovative tools in IO Discovery, Oral T-Cell Therapies for the Treatment of Cancer Patients and Discovery of novel bispecific antibody molecules to boost anti-tumor immunity

Our 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress to be held on 12th-13th March 2020 in London, UK would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.

WHAT TO EXPECT
Why Attend?
  • Exclusive conference to learn about antibodies, cellular therapy and immune-checkpoint research under one roof
  • Find out new case studies of immune-oncology projects in development
  • Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you
Key Highlights
  • Updates in development of monoclonal antibodies, ADC’s and Bispecific Ab’s
  • Immune Checkpoint Inhibitors and Combinations
  • Biomarkers and Cancer Vaccines
  • CAR-T cell therapy, T Cell Therapy
  • Tumor microenvironment
  • Oncolytic Viruses
  • Microbiome in Cancer Immunotherapy
Whats in it for you?
  • Explore the latest platforms and technologies on the market for development
  • Discuss the best tool for your research in immune-oncology
  • Share your work and achievements with your industry peers in the Poster Sessions 
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
Stefan Gluck

Stefan Gluck

Vice President
Celgene, USA

Stefan Gluck

Vice President
Celgene, USA
Eugene Zhukovsky

Eugene Zhukovsky

Chief Scientific Officer
Biomunex Pharmaceuticals, France

Eugene Zhukovsky

Chief Scientific Officer
Biomunex Pharmaceuticals, France
Sophia Karagiannis

Sophia Karagiannis

Professor, Translational Cancer Immunology and Immunotherapy
King’s College London, UK

Sophia Karagiannis

Professor, Translational Cancer Immunology and Immunotherapy
King’s College London, UK
Speakers
Roy Baynes

Roy Baynes

Senior Vice President and Head, Global Clinical Development, Chief Medical Officer
Merck Sharp & Dohme, USA

Roy Baynes

Senior Vice President and Head, Global Clinical Development, Chief Medical Officer
Merck Sharp & Dohme, USA
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets
Steven F. Schellings

Steven F. Schellings

Associate Director, Cellular Therapy, Account Management
Novartis, USA

Steven F. Schellings

Associate Director, Cellular Therapy, Account Management
Novartis, USA
Stefan Gluck

Stefan Gluck

Vice President
Celgene, USA

Stefan Gluck

Vice President
Celgene, USA
Bruno Tullia

Bruno Tullia

Assistant Professor
UPMC Hillman Cancer Center, USA

Bruno Tullia

Assistant Professor
UPMC Hillman Cancer Center, USA
Lindy Durrant

Lindy Durrant

Professor, Cancer Immunotherapy
University of Nottingham, UK

Lindy Durrant

Professor, Cancer Immunotherapy
University of Nottingham, UK
Junjian Liu

Junjian Liu

Vice President, Biologics Discovery
Innovent Biologics, China

Junjian Liu

Vice President, Biologics Discovery
Innovent Biologics, China
Sebastien Tabruyn

Sebastien Tabruyn

CSO
TransCure bioServices SAS, France

Sebastien Tabruyn

CSO
TransCure bioServices SAS, France
SPONSORS
Gold
example-image

Proteome Sciences

Silver
example-image

Ultivue

example-image

Lonza

example-image

Miltenyi Biotec

Sponsors & Exhibitors
example-image

Myriad RBM

example-image

TransCure bioServices

example-image

PromoCell

example-image

Marks & Clerk

example-image

GE Healthcare Life Sciences

example-image

Champions Oncology

PARTNERS
Supporting Association
MabDesign

MabDesign

One Nucleus

One Nucleus

Media Partners
example-image

Technology Networks

example-image

Pharma Journalist

example-image

PharmaTutor

example-image

GEN

LOCATION
ILEC Conference Center and IBIS London Earls Court, 47 Lillie Road, London, SW6 1UD
About the Hotel

A west London gem, The venue is known to the expert planner for the formidable flexibility and large capacity. The sleek design of the main hall, the London Suite, is positively favored for its ingenious partitioning and dazzling night-ambiance. Thus whether you are looking for an exhibition space, a meeting, an award ceremony, a corporate summer or Christmas party or a conference venue in London, our award-winning team will be certain to deliver the event you need and want.

PAST EVENT GALLERY